TrialClinical cancer research : an official journal of the American Association for Cancer Research2023

The Oral PI3Kδ Inhibitor Linperlisib for the Treatment of Relapsed and/or Refractory Follicular Lymphoma: A Phase II, Single-Arm, Open-Label Clinical Trial.

Tingyu Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.